课题基金 / 基金详情

Gene-edited hPSC-CMs as a novel strategy to eliminate graft-related arrhythmia

Gene-edited hPSC-CMs as a novel strategy to eliminate graft-related arrhythmia
基因编辑 hPSC-CM 作为消除移植物相关心律失常的新策略
批准号：
473933
负责人：
Al-attar Rasha
金额：
$6.56万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-10-01 至 2024-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=473933&lang=en
关键词：
Cell-Cell Communication Electrical Integration Genome Engineering Heart Failure Myocardial Infarction Pluripotent Stem Cell Derived-Cardiomyocytes Post-Translational Modification Regenerative Medicine Stem Cell Differentiation Stem Cell Transplan

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart failure affects more than 2.4 million Canadians, 578000 of whom are suffering from acute myocardial infarction (MI). The scarcity of the transplantable hearts prompted researchers to investigate using human pluripotent stem cell-derived cardiomyocyt
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金